Vectical Ointment
NDC Package 0299-2012-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Vectical (calcitriol) ointment is a medication used to treat psoriasis. This formulation utilizes a ointment delivery system. Marketed by Galderma Laboratories, L.p., this product is identified by NDC 0299-2012 and is authorized under FDA application NDA022087.

Identification & Billing

NDC Package Code
0299-2012-10
Package Description
1 TUBE in 1 CARTON / 100 g in 1 TUBE
Product Code
0299-2012
11-Digit Billing Format
00299201210
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
100 GM
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vectical
Non-Proprietary Name
Calcitriol
Substance Name
Calcitriol
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
CALCITRIOL 3 ug/g
Pharmacologic Class
Usage Information
This medication is used to treat psoriasis. Calcitriol is a form of vitamin D. It works by slowing down the growth of cells.

Regulatory & Marketing

Labeler Name
Galderma Laboratories, L.p.
Product Type
Human Prescription Drug
FDA Application #
NDA022087
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-01-2009
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0299-2012). Click a package code to view its specific billing and regulatory data.

0299-2012-05
5 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0299-2012-10 identifies a specific commercial package of 1 tube in 1 carton / 100 g in 1 tube of Vectical, a human prescription drug labeled by Galderma Laboratories, L.p.. This ointment is formulated for topical use and contains calcitriol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Galderma Laboratories, L.p. on February 01, 2009. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat psoriasis. Calcitriol is a form of vitamin D. It works by slowing down the growth of cells.

How is this Galderma Laboratories, L.p. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00299201210. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0299-2012-10
11-Digit CMS (5-4-2)
00299-2012-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.